Driving innovation in India’s pharma R&D through cell and gene therapy Saransh Chaudhary Sep 10, 2025 Saransh Chaudhary, President, Global Critical Care, Venus Remedies and CEO, Venus Medicine Research Centre highlights how…
ImmunoACT to lead journey of indigenous CAR-T cell therapy in India but market access a hurdle:… EP News Bureau Nov 1, 2023 As per ImmunoACT CEO, NexCAR19 will be available at a price of Rs 30-40 lakh ($36,000- $48,000), which is 1/10th of the cost of…
